1. Cancer statistics, 2020;Siegel;CA A Cancer J. Clin.,2020
2. Combining chemotherapy with PD-1 blockade in NSCLC;Mathew;Pharmacol. Ther.,2018
3. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung;Sanchez-Cespedes;Cancer Res.,2002
4. Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer;Kitajima;Cancer Discov.,2019
5. Evading the STING: LKB1 Loss Leads to STING Silencing and Immune Escape in KRAS-Mutant Lung Cancers;Della Corte;Cancer Discov.,2019